SEC Form 4 · accession 0001615774-16-005167
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliot Favus
Director
Period of report
Mar 31, 2016
Accepted (ET)
May 2, 2016 · 6:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.90 | Mar 31, 2016 | A | 1,500 | A | Dec 31, 2016 | Mar 31, 2026 | Common Stock | 1,500 | 1,500 | D |
| Stock Option (Right to Buy) | $5.66 | Apr 27, 2016 | A | 1,500 | A | Apr 27, 2016 | Apr 27, 2026 | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1Pursuant to the Company's ongoing obligation to grant to Mr. Favus options to purchase 1,500 shares at the end of each fiscal quarter as compensation for his service on Board Committees, 1,500 options were granted to Mr. Favus for the fiscal quarter ended March 31, 2016.